NYLIM
OPNT

New York Life Investment Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

New York Life Investment Management’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-61,912
Closed -$1.26M – 1448
2022
Q4 		$1.26M Buy
+61,912
New +$949K 0.01% 597

New York Life Investment Management's OPNT Position: Q1 2023 in Review

New York Life Investment Management sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 61,912 shares — an estimated $1.26M sold.

New York Life Investment Management first reported a position in OPNT in Q4 2022 and held it in 1 quarter. The position peaked at $1.26M in Q4 2022. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.

  • New York Life Investment Management reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • New York Life Investment Management sold 61,912 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $1.26M.
  • New York Life Investment Management first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • New York Life Investment Management's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $1.26M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on New York Life Investment Management's 13F filing for Q1 2023, filed 8 May 2023.